News

Roche (OTCQX:RHHBY) and Novartis (NYSE:NVS) are scheduled to meet with Swiss government officials this week amid U.S.
Novartis drew heightened retail chatter on Monday amid reports that Swiss ministers plan to meet this week with top ...
In 2012 Roche had over 82,000 employees worldwide and invested over 8 billion Swiss francs in R&D. The Group posted sales of 45.5 billion Swiss francs.
Swiss ministers have met with senior executives of pharmaceutical companies Roche and Novartis to discuss the outlook for the ...
The Swiss government met with executives of Roche Holding AG and Novartis AG to discuss the pharmaceutical industry’s ...
GENEVA (AP) — Swiss pharmaceuticals powerhouse Roche announced Tuesday it plans to invest $50 billion in the United States over the next five years, creating ...
GENEVA (AP) — Swiss pharmaceuticals powerhouse Roche announced Tuesday it plans to invest $50 billion in the United States over the next five years, creating 12,000 jobs. The Basel-based company ...
GENEVA (AP) — Swiss pharmaceuticals powerhouse Roche announced Tuesday it plans to invest $50 billion in the United States over the next five years, creating 12,000 jobs. The Basel-based company ...
Roche: The Undervalued Swiss Pharma Giant Jul. 13, 2022 4:54 PM ET Roche Holding AG (RHHBF) Stock, RHHBY Stock LLY, MRK, NONOF NVO NVS NVSEF PFE PPH RHHVF RHHBF RHHBY 8 Comments 12 Likes Mirco Lysek ...
Roche's head of diagnostics, Thomas Schinecker, is to take over as group chief executive next year, replacing Severin Schwan, who will become chairman after rejuvenating the Swiss drugmaker's ...
Switzerland's Roche said Thursday it has agreed to buy all the remaining shares in Genentech for $46.8 billion in a takeover described as the largest in Swiss corporate history.